June 12, 2025

Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Navigating the Biotechnology Landscape with a 4.46% Potential Upside

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is making waves in the biotechnology sector as it navigates the complex landscape of cancer therapeutics. With a market capitalization of..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a 157% Potential Upside and Robust Dividend Yield

XOMA Royalty Corporation (NASDAQ: XOMA) is capturing the attention of investors with its unique position in the biotechnology sector and an attractive potential upside of 157.74%...

Mereo BioPharma (MREO) Stock Analysis: Exploring the 187.96% Upside Potential

Mereo BioPharma Group plc (NASDAQ: MREO) is drawing significant attention in investor circles, primarily due to its substantial potential upside of 187.96%. This UK-based biopharmaceutical company,..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Unpacking a 55% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to genetic medicines. With a market..

Shopify Inc. (SHOP) Stock Analysis: Revenue Growth Soars with Robust 26.80% Increase

As Shopify Inc. (SHOP) continues to solidify its presence as a leading player in the technology sector, the company’s impressive revenue growth and strategic positioning offer..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: An Investor’s Insight into a Biotech with a 220% Upside Potential

Abeona Therapeutics Inc. (NASDAQ: ABEO) has caught the attention of the investment community with its promising potential upside of 220.40%, according to analyst ratings. This clinical-stage..

Varex Imaging Corporation (VREX) Stock Analysis: A Potential 90% Upside in the Medical Devices Sector

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector, specifically within the medical devices industry, presents a compelling investment opportunity with a notable..

Fulcrum Therapeutics, Inc. (FULC): Investor Outlook with 10.86% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is increasingly capturing the attention of biotech investors with its promising pipeline and a notable potential upside of 10.86% as per..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a 60.98% Potential Upside in the Healthcare Sector

In the dynamic landscape of the healthcare industry, Quantum-Si Incorporated (NASDAQ: QSI) stands out as an innovative player in the medical devices sector. With a market..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating Challenges Amidst the Digital Economy

AMTD Digital Inc. (HKD), a Paris-headquartered technology company, operates within the dynamic Software – Application industry. Despite its expansive reach across Europe, the United States, Hong..

Health Catalyst, Inc. (HCAT) Stock Analysis: A Promising 88% Potential Upside for Investors

Investors looking for a compelling opportunity in the healthcare sector may find Health Catalyst, Inc. (NASDAQ: HCAT) an intriguing prospect. With a market capitalization of $275.62..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 280% Upside in Biotechnology

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotechnology sector, offering investors a compelling opportunity in the ever-evolving landscape of precision oncology. As a San..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Lucrative Opportunity with 94% Upside Potential

For investors with an eye towards biotechnology, Palvella Therapeutics, Inc. (PVLA) represents a tantalizing opportunity in the healthcare sector. With its focus on rare genetic skin..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a Potential 74% Upside

Viemed Healthcare, Inc. (NASDAQ: VMD) presents an intriguing opportunity for investors looking to delve into the healthcare sector, specifically within the niche of medical devices and..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring a 21.69% Potential Upside for Investors

Fair Isaac Corporation (NYSE: FICO) is a behemoth in the technology sector with a remarkable market capitalization of $43.94 billion. Renowned for its pioneering role in..

Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: A 93.55% Potential Upside in Biotechnology

Tvardi Therapeutics, Inc. (TVRD) is commanding attention in the biotechnology sector with a compelling narrative for investors. Based in Sugar Land, Texas, Tvardi is a biotechnology..

Neuronetics, Inc. (STIM) Investor Outlook: Unveiling a Compelling 78.88% Potential Upside

Neuronetics, Inc. (NASDAQ: STIM) is capturing the attention of the healthcare investment community with a promising potential upside of 78.88%. This medical device company, specializing in..

Cidara Therapeutics (CDTX) Investor Outlook: A 61.97% Potential Upside in Biotech Innovation

Cidara Therapeutics, Inc. (CDTX), headquartered in San Diego, California, is a biotechnology company carving its niche in the healthcare sector by targeting serious diseases like cancer..

Senseonics Holdings, Inc. (SENS): Investor Outlook with a 196.71% Potential Upside

Senseonics Holdings, Inc. (SENS), a pioneering entity in the healthcare sector, is drawing attention with its remarkable potential upside of 196.71%. Headquartered in Germantown, Maryland, Senseonics..

ClearPoint Neuro Inc. (CLPT): Investor Outlook with a Promising 125% Upside Potential

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing the attention of investors with its innovative approach to medical devices in the healthcare sector, particularly in the realm..

Search

Funds

June 12, 2025

Search

Funds

June 12, 2025

FTSE 100

Funds